ISIDORe has been launched

"Integrated Services for Infectious Disease Outbreak Research" ...

Read more

TNA Call for proposal is now open

SUBMIT NOW

Read more

European Research Infrastructure on Highly Pathogenic Agents

Access to leading European high containment (BSL4 laboratories) & complementary facilities

Read more

Our Services for COVID-19 research

Learn more on access opportunities to our BSL3 and complementary facilities

Read more

ERINHA free of charge Special SARS-CoV-2 transnational access (TNA)

Learn more on application modalities

Read more

ERINHA Scientific Strategy

From Discovery to Prevention

Read more

Follow our twitter: @ERINHA_RI

You can contact us here

Access to our intranet here

Download our portfolio here

ERINHA's concept

European distributed research infrastructure of Bio Safety Level 3 and 4 (BSL3 & BSL4) facilities providing access to perform large-scale research projects

Read more

Scientific strategy

From Discovery to Prevention: ERINHA’s Research Approach

Read more

Pathogens We Study

ERINHA focuses on high-consequence pathogens of Risk Group 4 with no available countermeasures and high transmission and mortality rates

Read more

Unique facilities and scientists

The cutting edge research performed at ERINHA is made possible by a range of highly specialised European bio-contained facilities and unique expertise

Read more

News & Events

Newsletter March 2022

ESFRI 20th anniversary conference: European Research Infrastructures at the heart of scientific discoveries

ISIDORe: A New Approach to Pandemic Preparedness Research in Europe

Twitter feeds

Retweet on Twitter ERINHA Retweeted

ISIDORe @isidore_eu·

All countries remain 'dangerously unprepared’ for a future disease outbreak according to the 2021 Global Health Security Index.

Read more about this Index by @NTI_WMD and @JHSPH_CHS ⬇️

#prepardness #pandemic #COVID19 #publichealth
https://globalhealthnow.org/2021-12/dangerously-unprepared-new-report-faults-countries-pandemic-readiness-again

Reply on Twitter 1527609249467191298 Retweet on Twitter 15276092494671912983 Like on Twitter 15276092494671912984 Twitter 1527609249467191298

“The current, unprecedented in modern times, global pandemic of COVID-19, shows the necessity of global collaborative approach. ERINHA was created to allow academia and industry to have easier access to Europe’s top high containment research facilities to advance research on highly infectious diseases and develop more effective diagnostics, therapeutics, and vaccines. This cooperative scheme allows rapid testing of new or repurposed drugs, optimized in vivo efficacy studies, and opens the door to industry, SMEs and public researchers, to test their innovative products against existing and emerging infectious diseases.”

Dr Hervé RAOUL, ERINHA Chair of the Executive Board

Members

Our adress

ERINHA AISBL
98, rue du Trône / Boîte n°4
B-1050 Bruxelles

ERINHA AISBL CCU
101, rue Tolbiac – 75013 Paris

contact@erinha.eu

Extra links

Newsletters

Subscribe for latest articles and resources

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Necessary

Toujours activé

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non Necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

Cookie	Type	Durée	Description
test_cookie	0	11 months	This cookie is set by doubleclick.net. The purpose of the cookie is to determine if the users'' browser supports cookies.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Cookie	Type	Durée	Description
YSC	1	session	This cookies is set by Youtube and is used to track the views of embedded videos.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Type	Durée	Description
GPS	1	29 minutes	This cookie is set by Youtube and registers a unique ID for tracking users based on their geographical location

Advertisement

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

Cookie	Type	Durée	Description
IDE	1	1 years 23 days 23 hours 59 minutes	Used by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
VISITOR_INFO1_LIVE	1	5 months 26 days 23 hours 59 minutes	This cookie is set by Youtube. Used to track the information of the embedded YouTube videos on a website.